PHOSCAN CHEMICAL ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO, October 16, 2014 - PhosCan Chemical Corp. (TSX: FOS) ("PhosCan") announces that it intends to renew its normal course issuer bid (the "Renewed Bid") for an additional one year period. Under the Renewed Bid, PhosCan may repurchase up to

10,000,000 of its common shares, representing approximately 8.53% of the public float of
PhosCan, which is currently 117,188,844 common shares. As of October 15, 2014, there were
156,199,833 issued and outstanding common shares of PhosCan. Purchases will be made through the facilities of the TSX and other designated exchanges and alternative trading systems in Canada at the prevailing market price of the shares. All shares purchased under the Renewed Bid will be cancelled. PhosCan currently has in place a normal course issuer bid which expires October 18, 2014 (the "Existing Bid") and previously had in place a normal course issuer bid which expired October 17, 2012 and then October 18, 2013. During the past year, PhosCan has purchased an aggregate of 4,023,755 common shares at an average weighted price of $0.273 per share under the Existing Bid.
PhosCan has received approval from the TSX to commence the Renewed Bid on October 21,
2014. The Renewed Bid will terminate on October 20, 2015 or on any such earlier date as PhosCan may complete its purchases or otherwise terminate the Renewed Bid. Pursuant to TSX policies, daily purchases made by PhosCan pursuant to the Renewed Bid will not exceed
19,510 common shares, being 25% of the average daily trading volume of 78,041 shares on the TSX for the past six months, subject to certain exceptions (including block purchases) prescribed by the TSX. Purchases pursuant to the Renewed Bid will be made through RBC Dominion Securities Inc.
To the knowledge of PhosCan, no director, senior officer or insider of PhosCan currently intends to sell any common shares under the Renewed Bid. However, sales by any such persons through the facilities of the TSX may occur if the personal circumstances of such person changes or such person makes a decision unrelated to the Renewed Bid. The benefits to any such person whose shares are purchased would be the same as the benefits available to all other holders whose shares are purchased under the Renewed Bid.
PhosCan believes that the purchase of its common shares is an appropriate use of funds, since the current market price is less than the cash value per common share.
For more information please contact: Stephen Case, President & CEO
PhosCan Chemical Corp. Tel: (416) 972-9222

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking" statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of PhosCan to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. These forward-looking statements are made as of the date of this press release, and PhosCan assumes no obligations to update or revise them to reflect new events or circumstances.

- 2 -